Amphastar Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
AMPH Amphastar Pharmaceuticals Inc
FPAY FlexShopper Inc
TCS Container Store Group Inc
CMSA CMS Energy Corp
LULU Lululemon Athletica Inc
MGY Magnolia Oil & Gas Corp
LGHL Lion Group Holding Ltd
C Citigroup Inc
SYBX Synlogic Inc
MDBH Public Ventures LLC
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Amphastar Pharmaceuticals, Inc. is a bio-pharmaceutical company. The Company is focused on developing, manufacturing, marketing and selling generic and injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (API) products. It operates through two segments: finished pharmaceutical products and API products. The finished pharmaceutical products segment manufactures, markets and distributes Primatene MIST, epinephrine, glucagon, phytonadione, lidocaine, enoxaparin, naloxone, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes RHI API and porcine insulin API for external customers and internal product development. Primatene Mist is an epinephrine inhalation product, which is indicated for the temporary relief of mild symptoms of intermittent asthma. Its portfolio also includes BAQSIMI (BAK-see-mee), which is used to treat very low blood sugar in people with diabetes ages 4 years and above.

Closing Price
$45.51
Day's Change
-0.15 (-0.33%)
Bid
--
Ask
--
B/A Size
--
Day's High
46.13
Day's Low
45.27
Volume
(Light)
Volume:
160,841

10-day average volume:
945,326
160,841
  • Prev Close
    45.66
  • Today's Open
    46.12
  • Day's Range
    45.27-46.13
  • Avg Vol (10-day)
    945.3K
  • Last (time)
    4:00p ET 09/22/23
  • Last (size)
    1
  • 52-Wk Range
    26.76 - 67.66
    LowHigh
  • (11/08/22 - 08/09/23)
    70.07%
  • 42.3%
  • Market Cap
    2.2B
  • Shares Outstanding
    48.9M
  • 1.95
  • 23.35x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.9
  • 64.56
  • (% of float 08/31/23)
    3.40

Latest News

September 19, 2023
4:50 pm ET
Zacks
September 14, 2023
8:30 am ET
Zacks
September 13, 2023
4:50 pm ET
Zacks
1:01 pm ET
Accesswire
1:01 pm ET
Accesswire
12:49 am ET
Accesswire
September 11, 2023
5:46 pm ET
Accesswire
5:00 pm ET
Accesswire
4:45 pm ET
Accesswire
August 31, 2023
4:05 pm ET
Accesswire
August 18, 2023
12:54 pm ET
Zacks
August 17, 2023
10:34 am ET
Zacks
August 14, 2023
12:22 pm ET
Zacks
6:57 am ET
Zacks
6:01 am ET
Zacks
August 11, 2023
11:45 am ET
Zacks
11:06 am ET
Zacks
9:33 am ET
Zacks
8:40 am ET
Zacks
August 10, 2023
8:15 am ET
Zacks
August 08, 2023
7:30 pm ET
Zacks
4:06 pm ET
Accesswire
August 03, 2023
10:22 am ET
Zacks
August 02, 2023
4:10 pm ET
Accesswire
June 30, 2023
4:05 pm ET
Accesswire
June 27, 2023
12:51 pm ET
Zacks
April 24, 2023
6:55 am ET
MarketWatch
March 30, 2023
10:10 am ET
Zacks
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.